JP2023126658A5 - - Google Patents

Download PDF

Info

Publication number
JP2023126658A5
JP2023126658A5 JP2023119196A JP2023119196A JP2023126658A5 JP 2023126658 A5 JP2023126658 A5 JP 2023126658A5 JP 2023119196 A JP2023119196 A JP 2023119196A JP 2023119196 A JP2023119196 A JP 2023119196A JP 2023126658 A5 JP2023126658 A5 JP 2023126658A5
Authority
JP
Japan
Prior art keywords
agents
transgene
medicament
administration
raav
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023119196A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023126658A (ja
Filing date
Publication date
Priority claimed from PCT/US2020/028269 external-priority patent/WO2020214672A1/en
Application filed filed Critical
Publication of JP2023126658A publication Critical patent/JP2023126658A/ja
Publication of JP2023126658A5 publication Critical patent/JP2023126658A5/ja
Pending legal-status Critical Current

Links

JP2023119196A 2019-04-15 2023-07-21 導入遺伝子発現のための方法及び組成物 Pending JP2023126658A (ja)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201962833979P 2019-04-15 2019-04-15
US62/833,979 2019-04-15
US201962926317P 2019-10-25 2019-10-25
US62/926,317 2019-10-25
US202062967219P 2020-01-29 2020-01-29
US62/967,219 2020-01-29
PCT/US2020/028269 WO2020214672A1 (en) 2019-04-15 2020-04-15 Methods and compositions for transgene expression
JP2021561893A JP2022529470A (ja) 2019-04-15 2020-04-15 導入遺伝子発現のための方法及び組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021561893A Division JP2022529470A (ja) 2019-04-15 2020-04-15 導入遺伝子発現のための方法及び組成物

Publications (2)

Publication Number Publication Date
JP2023126658A JP2023126658A (ja) 2023-09-07
JP2023126658A5 true JP2023126658A5 (https=) 2023-10-24

Family

ID=70779846

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021561893A Pending JP2022529470A (ja) 2019-04-15 2020-04-15 導入遺伝子発現のための方法及び組成物
JP2023119196A Pending JP2023126658A (ja) 2019-04-15 2023-07-21 導入遺伝子発現のための方法及び組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021561893A Pending JP2022529470A (ja) 2019-04-15 2020-04-15 導入遺伝子発現のための方法及び組成物

Country Status (13)

Country Link
US (1) US20220195461A1 (https=)
EP (1) EP3955970A1 (https=)
JP (2) JP2022529470A (https=)
KR (1) KR20220047538A (https=)
CN (1) CN114340683A (https=)
AU (1) AU2020257182A1 (https=)
BR (1) BR112021020706A2 (https=)
CA (1) CA3137078A1 (https=)
IL (1) IL287262A (https=)
MX (1) MX2021012682A (https=)
PH (1) PH12021552609A1 (https=)
SG (1) SG11202111353QA (https=)
WO (1) WO2020214672A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017139381A1 (en) 2016-02-08 2017-08-17 University Of Iowa Research Foundation Methods to produce chimeric adeno-associated virus/bocavirus parvovirus
CA3016985C (en) 2016-03-07 2023-07-04 University Of Iowa Research Foundation Aav-mediated expression using a synthetic promoter and enhancer
WO2017205739A1 (en) 2016-05-26 2017-11-30 University Of Iowa Research Foundation cis AND trans REQUIREMENTS FOR TERMINAL RESOLUTION OF HUMAN BOCAVIRUS 1
US11142775B2 (en) 2017-01-13 2021-10-12 University Of Iowa Research Foundation Bocaparvovirus small noncoding RNA and uses thereof
CN114641318A (zh) * 2019-04-15 2022-06-17 衣阿华大学研究基金会 用于治疗囊性纤维化的组合物和方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478745A (en) 1992-12-04 1995-12-26 University Of Pittsburgh Recombinant viral vector system
WO1995013365A1 (en) 1993-11-09 1995-05-18 Targeted Genetics Corporation Generation of high titers of recombinant aav vectors
PT728214E (pt) 1993-11-09 2004-11-30 Ohio Med College Linhas celulares estaveis capazes de expressar o gene de replicacao do virus adeno-associado
CA2207927A1 (en) 1994-12-06 1996-06-13 Targeted Genetics Corporation Packaging cell lines for generation of high titers of recombinant aav vectors
US5656785A (en) 1995-08-07 1997-08-12 The Charles Stark Draper Laboratory, Inc. Micromechanical contact load force sensor for sensing magnitude and distribution of loads and tool employing micromechanical contact load force sensor
AU5445998A (en) 1996-11-19 1998-06-10 Surgx Corporation A transient voltage protection device and method of making same
JP2001506133A (ja) 1996-12-18 2001-05-15 ターゲティッド ジェネティクス コーポレイション 組換えaavベクターの産生における使用のための、aavスプリット−パッケージング遺伝子およびこのような遺伝子を含む細胞株
AU2004227358B8 (en) * 2003-03-31 2009-12-10 Targeted Genetics Corporation Compounds and methods to enhance rAAV transduction
US9233131B2 (en) 2003-06-30 2016-01-12 The Regents Of The University Of California Mutant adeno-associated virus virions and methods of use thereof
US9169492B2 (en) * 2010-02-05 2015-10-27 The University Of North Carolina At Chapel Hill Compositions and methods for enhanced parvovirus transduction
RS57739B1 (sr) * 2013-03-14 2018-12-31 Translate Bio Inc Kompozicije cftr irnk i postupci i upotrebe u vezi sa njima
WO2014168953A1 (en) * 2013-04-08 2014-10-16 University Of Iowa Research Foundation Chimeric adeno-associated virus/ bocavirus parvovirus vector
EP3800191B1 (en) * 2014-03-17 2025-08-20 Adverum Biotechnologies, Inc. Compositions and methods for enhanced gene expression in cone cells
WO2017139381A1 (en) * 2016-02-08 2017-08-17 University Of Iowa Research Foundation Methods to produce chimeric adeno-associated virus/bocavirus parvovirus
CA3016985C (en) * 2016-03-07 2023-07-04 University Of Iowa Research Foundation Aav-mediated expression using a synthetic promoter and enhancer
CA3040179A1 (en) * 2016-10-19 2018-04-26 Adverum Biotechnologies, Inc. Modified aav capsids and uses thereof
CN106928336B (zh) * 2017-01-20 2019-09-24 首都医科大学附属北京儿童医院 囊性纤维化患者的cftr基因突变形式及其应用
JP2020510424A (ja) * 2017-02-28 2020-04-09 アドヴェラム バイオテクノロジーズ, インコーポレイテッド 改変aavカプシドおよびその使用
NZ756587A (en) * 2017-03-15 2025-12-19 Univ North Carolina Chapel Hill Polyploid adeno-associated virus vectors and methods of making and using the same
CN114641318A (zh) * 2019-04-15 2022-06-17 衣阿华大学研究基金会 用于治疗囊性纤维化的组合物和方法

Similar Documents

Publication Publication Date Title
JP2023126658A5 (https=)
Ferrari et al. Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis
JP6373763B2 (ja) Aavベクター成分、及び、細胞、臓器並びに組織への遺伝子導入のための方法
JP2022529457A5 (https=)
JP6495273B2 (ja) 変異aav、及び、細胞、臓器並びに組織への遺伝子導入のための組成物、方法並びに使用法
JP2023544683A5 (https=)
JP2023551903A5 (https=)
JP2020203894A5 (https=)
US20240024507A1 (en) Novel compositions with tissue-specific targeting motifs and compositions containing same
JP2022535745A5 (https=)
WO2023060269A4 (en) Recombinant adeno-associated viruses for targeted delivery
JP2020050668A5 (https=)
CA3137015A1 (en) Compositions and methods for treatment of cystic fibrosis
McLachlan et al. Progress in respiratory gene therapy
JP2022539156A (ja) ヒアルロン酸を用いた眼組織へのaav媒介形質導入の増強
JP2022529470A (ja) 導入遺伝子発現のための方法及び組成物
JP2023536570A5 (https=)
Gautam et al. Delivery systems for pulmonary gene therapy
JP2020527167A5 (https=)
JP2024133479A5 (https=)
McClain et al. Vector serotype screening for use in ovine perinatal lung gene therapy
JP2023509462A5 (https=)
JP7756284B2 (ja) コロナウイルス誘発性疾患を治療するためのオールインワンaavベクター
BR112021014400A2 (pt) Genoma do vírus do herpes recombinante, vírus do herpes, composição farmacêutica, e, métodos para intensificar, aumentar, elevar e/ou suplementar os níveis de um polipeptídeo cftr em uma ou mais células, para reduzir ou inibir a destruição progressiva do pulmão, para fornecer alívio profilático, paliativo ou terapêutico de um ou mais sinais ou sintomas de fibrose cística e para fornecer alívio profilático, paliativo ou terapêutico de um ou mais sinais ou sintomas de copd
JP2003505518A5 (https=)